Instil Bio, Inc.
TIL· Nasdaq
Released Mar 27, 2026, before the open
10-K filed Mar 27, 2026, 86 days after period end · 0001789769-26-000019
| Metric | Q4 2025 | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$71.40M | -$11.90M | -$12.93M | -$53.84M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Instil Bio, Inc. · CIK 1789769 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Dec 31, 2025 · filed Mar 27, 2026 · 86 d after period end
6.4% from the close of Mar 26, 2026 to the close of Mar 27, 2026, the first after the release.